Gearing Up for RESI Boston: Master Your Fundraising & Development Strategy at the Pre-RESI Biotech Forum

July 28, 2026 ~ Next Phase Admin ~ Leave a comment

By Max Braht, VP of Business Development, LSN

On Monday, September 21, 2026, the day before RESI Boston 2026, Life Science Nation (LSN) and RESI Boston Silver Sponsor, Certara, will host a Biotech Forum focused on Developing Investor Ready Strategies.

Designed for early-stage biotech companies, the workshop will help founders evaluate their company’s readiness for a global fundraising campaign by identifying opportunities to strengthen their development strategy and reduce key scientific, clinical, regulatory, commercial, and fundraising risks. Through expert-led sessions and interactive discussions, attendees will gain practical insights into what investors look for during diligence, how to build a credible development roadmap, and how to position their company for successful fundraising.

Held immediately before RESI Boston, the workshop gives companies the opportunity to refine their strategy and messaging before meeting with investors and strategic partners throughout RESI.

Not yet signed up for RESI Boston 2026: Register Here

We look forward to welcoming you to the CIC in Cambridge as we kick off RESI Boston 2026 with a day dedicated to helping innovative biotech companies become truly investor ready.

Cross-Border Investor Luncheon at RESI Boston 2026

July 21, 2026July 24, 2026 ~ Next Phase Admin ~ Leave a comment

A private, screened luncheon for regional and international investors seeking syndicate partners.

RESI Boston | Wednesday, September 23 | 75 Seats

RSVP for Cross-Border Investor Luncheon Today

By Dennis Ford, Founder & CEO, Life Science Nation (LSN)

Nearly nine out of ten life science startups fail. Not because the science is poor, but because they never connect to the right capital and strategic partners. Solving that is the reason Life Science Nation exists, and for more than fifteen years our work has come down to one thing: finding parties who need each other and matching them.

As some readers know, LSN has been addressing this pervasive dilemma through the LSN Labs Anchor Node Program. An Anchor Node combines LSN’s commercialization methodology and global capital formation network with a regional partner’s laboratories, entrepreneurial programs, and operating platform to produce investment-ready life science companies.

As we expanded the Anchor Node Program across Boston, Australia, Japan, Korea, the UK, and Brazil, a clear pattern emerged: regional partners constantly brought their local VCs to the table seeking international capital. At the same time, our own data across five global RESI events revealed that twenty percent of all partnering meetings were already investor-to-investor.

So we decided to formalize it, and provide a dedicated room for these partners to connect.

The Cross-Border Investor Luncheon, CBIL, is a private luncheon at RESI Boston for regional and international investors seeking syndicate partners. Regional investors have access to exceptional companies that often never reach international investors. International investors have access and reach that regional funds cannot build alone. Both are looking for the same thing across Asia, Europe, North America, and South America.

Attendance is screened. CBIL is for active investors seeking syndicate partners outside their own region, whether that means bringing international capital into local deals or gaining access to deal flow in regions where they have no presence.

Taking place on Wednesday, September 23, CBIL follows the format of the Global Family Office BioForum luncheon (GFOB luncheon takes place on Tuesday, September 22), now in its eighth year. Across those eight years, GFOB has brought family offices together to find each other, form alliances, and build syndicates. CBIL is the natural next step, applying the same private, curated format to the international investor community.

“The future of life science investing is not just finding great companies. It is finding great syndicate partners in the global arena.”

Dennis Ford, Founder and CEO, Life Science Nation

Wednesday, September 23 | Private luncheon | Screened RSVP | 75 seats

Every RSVP is reviewed. Request your seat today!

RSVP for Cross-Border Investor Luncheon Today

Prepare for RESI Boston: Join Our Pre Conference Webinar Series

July 21, 2026July 21, 2026 ~ Next Phase Admin ~ Leave a comment

By Karen Deyo, VP of Product, Israel BD, LSN

Success at RESI Boston begins long before the conference starts. In the weeks leading up to the event, Life Science Nation is hosting a series of complimentary educational webinars designed to help innovators strengthen every aspect of their fundraising journey. From refining your messaging and marketing collateral to learning about emerging technologies, preparing your investor pitch, and navigating the RESI partnering system, these sessions will help you arrive at RESI Boston ready to maximize every opportunity.

Whether you are preparing for investor meetings, applying to the Innovator’s Pitch Challenge, or looking to sharpen your fundraising strategy, these webinars provide practical insights you can immediately put into action.

Branding and Messaging from Seed to Series B: Building Marketing Collateral That Attracts Investors

Monday, August 3 | 11:00 AM ET

Your marketing collateral is often the first impression investors have of your company. This interactive workshop explores how to build a compelling and consistent investment story across your tagline, elevator pitch, executive summary, one page tear sheet, and pitch deck.

Attendees will learn how to effectively communicate the three pillars’ investors evaluate: your technology, your market opportunity, and your business strategy while tailoring messaging for different audiences and strengthening materials through investor feedback.

Register: https://go.lifesciencenation.com/osolca

RESI Boston Partnering Tutorial

Tuesday, August 18 | 11:00 AM ET

The RESI partnering system is one of the most valuable tools available to attendees, but maximizing its potential requires the right strategy. Join the Life Science Nation team for a walkthrough of the partnering platform, including how to identify the best fit investors and strategic partners, manage outreach effectively, develop a successful meeting request strategy, follow up with purpose, and leverage RESI content to maximize your conference experience.

Registration: https://go.lifesciencenation.com/q5QmbZ

Educational Webinars Hosted by RESI Boston Sponsors

In addition to Life Science Nation’s educational workshops, RESI Boston sponsors are offering complimentary webinars that showcase their expertise and provide valuable insights for the life science community.

Biocytogen Webinar
RenSuper Workstation: An AI Driven Antibody Discovery Platform From Target to Antibody Leads in Click
Wednesday, August 26 | 1:00 PM ET

Discover how Biocytogen’s AI driven RenSuper Workstation integrates immunization, next generation sequencing, AI powered high throughput screening, and experimental validation to accelerate antibody discovery and deliver development ready antibody candidates.

Register: https://go.lifesciencenation.com/tooA7s

RSM Webinar – Life Sciences Strategic Managed Services Leader

RSM, a global consulting, tax, and assurance firm with deep expertise serving the life sciences industry, will host a complimentary webinar focused on helping emerging companies navigate growth, fundraising, and commercialization.

Tuesday, September 1 | 12:00 PM ET

Join RESI Boston sponsor RSM for a complimentary webinar featuring insights and expertise for life science companies preparing to grow, raise capital, and navigate today’s evolving business landscape.

Register: https://go.lifesciencenation.com/deHMNq

Maximizing the Power of Your Pitch

Thursday, September 17 | 11:00 AM ET

Just days before RESI Boston begins, this workshop will help innovators prepare one of the most important moments of fundraising: the investor pitch.

Learn practical techniques for crafting a compelling presentation, navigating the application process, delivering an engaging pitch, and confidently handling investor led questions and answers. Whether you are participating in the Innovator’s Pitch Challenge or meeting investors one on one, this session will help you present your company with confidence.

Register: https://go.lifesciencenation.com/akrBbw

Together, these webinars provide a comprehensive roadmap for RESI Boston preparation. From developing a compelling investment story and learning from industry experts to mastering the partnering platform and delivering a winning pitch, each session is designed to help you maximize every investor interaction before the conference begins.

Register for the webinars that best fit your fundraising needs and arrive at RESI Boston fully prepared to connect with investors, strategic partners, and industry leaders.

Finding the Right Investors Starts with the Right Data

July 21, 2026July 21, 2026 ~ Next Phase Admin ~ Leave a comment

By Max Braht, VP of Business Development, LSN

For early-stage life science companies, fundraising success depends on connecting with investors who are actively looking for technologies like yours. That is why Life Science Nation (LSN) has spent years building one of the industry’s most comprehensive investor databases, designed specifically to help innovators identify the right capital partners.

Unlike generic databases built through web scraping, the LSN Investor Database is curated directly through 1:1 interviews with investors and strategic in-licensors, providing startups with insights that go far beyond basic contact information or what you find on an investor’s website. Each investor profile includes valuable details such as typical check size, preferred modalities and indications, stage of development, geographic focus, and more, allowing companies to build a highly targeted fundraising strategy.

The database includes more than 4,000 global investment firms across 10 distinct investor categories and over 12,000 investor contacts spanning therapeutics, medical devices, diagnostics, digital health, and other life science sectors. Whether you are raising a Seed, Series A, or Series B round, identifying investors who are an actual fit can save significant time and improve the quality of your outreach.

Not sure where to begin? Life Science Nation is offering a complimentary investor search to help companies uncover potential investors that may not already be on their radar. The search demonstrates how the LSN Investor Database can provide each company with a curated list of investors matched to their technology and stage of development, along with contact information to then go out and execute on a fundraising campaign.

LSN is also happy to offer a free Fundraising Readiness Assessment through our internally developed AI Agent. The assessment will generate a 6-page report that can be used to help transition your companies’ story from an “interesting technology” into a compelling and ultimately investable company.

Book your free investor search today or complete the AI assessment to take the first step toward building a more focused and effective fundraising campaign.

Book Your Free Investor Search Today

RESI Boston 2026 Agenda Announced: Two Days of Investor Insights, Partnership Strategy, and Networking

July 14, 2026July 14, 2026 ~ Next Phase Admin ~ Leave a comment

By Claire Jeong, Chief Conference Officer, Vice President of Investor Research, Asia BD, LSN

The agenda for RESI Boston 2026 is here, offering attendees an in-depth look at the conversations shaping the future of early-stage life science investment. Taking place September 22–23 at The Westin Copley Place in Boston, followed by virtual partnering days on September 25, 28, and 29, the expanded two-day in-person conference delivers more opportunities than ever to connect with investors, strategic partners, and industry leaders.

This year’s program reflects the evolving priorities of the healthcare investment ecosystem, with sessions designed to help innovators better understand today’s fundraising environment while building the relationships needed to move their companies forward.

Day one begins by exploring why Boston remains one of the world’s premier biotechnology hubs before examining key topics including partnering with health systems, how venture investors evaluate early-stage therapeutics, securing pharmaceutical partnerships, corporate venture capital strategies, digital health innovation, and the growing influence of family offices in healthcare investing. The day also features the Global Family Office Bioforum (GFOB), an invite-only private networking lunch that brings together select family office investors for high-value discussions and relationship building.

On day two, programming shifts toward emerging investment trends with sessions highlighting angel investing, women’s health, impact investing, and the increasingly important role of mission-driven capital. The conference concludes with two Reverse VC Pitch sessions, where investors take the stage to present directly to entrepreneurs, providing attendees with valuable insight into investment priorities, fund strategies, and what investors are actively seeking in new opportunities. The day also features the exclusive Global VC Connect Lunch, creating another dedicated opportunity for venture capital investors to build meaningful connections.

As always, RESI programming is designed to provide practical insights rather than theory. Whether attendees are preparing for their next fundraising round, pursuing strategic partnerships, or looking to better understand today’s investment landscape, every panel is curated to deliver actionable perspectives from experienced investors and industry leaders.

Combined with RESI’s partnering platform and three additional days of virtual meetings, the conference offers a comprehensive environment for companies seeking to advance fundraising and business development efforts.

Join the RESI Speaker Lineup

Are you an investor or strategic partner with valuable insights to share with early-stage life science companies? We are looking for dynamic speakers to join our RESI panels. Click here to submit your Speaker Interest Form today!

Registration is now open, with super early bird pricing currently available. Companies planning to attend are encouraged to register early to secure the best available rates and begin preparing for one of the most anticipated life science investment events of the year.

Save the Date – Global Family Office BioForum at RESI Boston – Where Active Investors Connect, Collaborate, and Co-Invest

July 14, 2026 ~ Next Phase Admin ~ Leave a comment

September 22, 2026 | Westin Copley Place | RESI Boston

By Joey Wong, Director of Investor Research, Hong Kong BD, LSN

Life Science Nation (LSN) is pleased to announce the formal program for the Global Family Office BioForum (GFOB) and invites qualified family office investors to participate in this exclusive gathering.

Held during the Redefining Early-Stage Investments (RESI) Conference on Tuesday, September 22, at the Westin Copley Place in Boston, GFOB provides a private, curated environment for family offices to:

Exchange strategies across asset classes and investment themes
Share deal flow insights and emerging biotech opportunities
Explore co-investment partnerships in early-stage therapeutics and healthcare innovation

In addition to the private luncheon and networking session, GFOB will feature a Family Office Investors Panel open to all RESI attendees. The panel will spotlight perspectives from seasoned family office investors who are actively deploying capital in the life sciences and healthcare sectors.

If you are a Family Office and would like to attend the Family Office BioForum Luncheon

RSVP for GFOB Here

Only active family office investors will be accepted.

Register for RESI Boston 2026
Secure your ticket and access over 500 investors across family offices, venture capital, pharma, and strategic partners.

More Connections, Better Matches: Inside RESI San Diego’s 1,000+ Investor Meeting Success

July 14, 2026July 14, 2026 ~ Next Phase Admin ~ Leave a comment

By Sougato Das, President and COO, LSN

Sougato-Das

RESI San Diego was a powerhouse gathering of 300+ active early-stage life science investors including VCs, angels, family offices, CVCs, venture philanthropy, and pharma external innovation scouts across 10 distinct categories.

What made this event truly remarkable wasn’t just the sheer number of attendees, but their high level of engagement. Throughout the five-day hybrid conference, innovators and capital providers initiated thousands of high-value conversations, reinforcing why RESI remains a premier venue for early-stage companies seeking Seed, Series A, and Series B financing.

RESI San Diego: Partnering Success by the Numbers
The event saw incredible partnering activity, showcasing both high volume and improved precision:

11,000+ Partnering requests submitted.
1,400+ Accepted meetings.

This jump in efficiency reflects a growing emphasis on targeted outreach and thoughtful meeting selection, helping attendees spend less time chasing cold leads and more time speaking with organizations that closely match their technology and fundraising goals.

Furthermore, the hybrid format delivered maximum flexibility.

The RESI Differentiator: Why Our Matches are Stronger
Other industry conferences often suffer from half-empty investor profiles, making it incredibly difficult for fundraising startups to know whom to target. RESI is built differently.

Vetted, Highly-Detailed Profiles: Our dedicated Investor Research Team manually populates and verifies every single investor profile in the system. You get the exact detail you need to determine if an investor is a legitimate fit.
No “Undercover” Service Providers: Our team meticulously screens every participant to ensure that anyone registered as an investor is actually a legitimate capital provider ready to invest, not financial service providers in disguise.
High Visibility on Site: With investors easily identified by their red registration badges, initiating spontaneous, high-value conversations during in-person days was easier than ever.

Maintain Your Fundraising Momentum
Fundraising is a relationship-driven process. The strongest outcomes rarely come from a single meeting; they are built through multiple touchpoints over time. Participating in sequential RESI conferences allows you to strengthen existing relationships, introduce new data milestones, and refine your pitch.

Super Early Bird registration is now open for our upcoming landmark events:

RESI Boston (September 2026): Held during Biotech Week Boston, featuring 2 days of expanded in-person programming and 3 days of virtual partnering. (Save $300 if you register by this Friday, July 17!)
RESI JPM 2027 (January 2027): Returning to San Francisco during JPM Healthcare Week, the busiest week in healthcare venture capital. 2 days of live networking at the SF Marriott Marquis, followed by 3 days of global virtual partnering.

Lock in the lowest rates of the season today, secure your Super Early Bird pricing, and keep your fundraising momentum moving forward!